Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ariannigna
    Junior Member
    • Nov 2009
    • 3

    #1

    single end seq

    Hello from London!
    I'm planning a project of whole exome sequencing on human samples.
    We bought the 2.1M Nimblegen array and are going to seq on GAII.
    the library is based on a single end sequencing
    I have to decide the read lenght with the GAII but I don't understand how it'll affect the coverage.
    With a single end is it better to have short (36bp) or long (75bp)read lenght?
  • Xi Wang
    Senior Member
    • Oct 2009
    • 317

    #2
    Originally posted by ariannigna View Post
    Hello from London!
    I'm planning a project of whole exome sequencing on human samples.
    We bought the 2.1M Nimblegen array and are going to seq on GAII.
    the library is based on a single end sequencing
    I have to decide the read lenght with the GAII but I don't understand how it'll affect the coverage.
    With a single end is it better to have short (36bp) or long (75bp)read lenght?
    The mappability of short reads and long reads are different. Longer reads will have more percentage of reads that can be uniquely mapped to the reference genome.
    Xi Wang

    Comment

    • ariannigna
      Junior Member
      • Nov 2009
      • 3

      #3
      thanks for you reply.
      so if I decide to go for the single end seq and a short read lenght I should end up with higher coverage ... but higher chance to miss indels and duplication?

      Comment

      • Xi Wang
        Senior Member
        • Oct 2009
        • 317

        #4
        When a short read map back to the reference genome, there would be more than one loci that the short read hits. This is due to the sequence repeat of a genome. Also you can refer to the UCSC track "mappability":

        Xi Wang

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        35 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...